In A549 human lung adenocarcinoma cells (ACCs) and Calu-1 lung epidermoid carcinoma cells, pretreatment with apigenin significantly reduced cell viability at all TRAIL concentrations tested compared to controls (Fig. 1a). This evidence concerns the gene TNFSF10 and squamous cell carcinoma.